Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence
暂无分享,去创建一个
[1] H. DeLuca,et al. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.
[2] T. Meehan,et al. The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆ , 2002 .
[3] S. Walsh,et al. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. , 2000, American journal of public health.
[4] B. Györffy,et al. Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus. , 2002, European journal of endocrinology.
[5] M. Uskoković,et al. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. , 2002, Diabetes.
[6] C. Folwaczny,et al. Candidate Genes Colocalized to Linkage Regions in Inflammatory Bowel Disease , 2002, Digestion.
[7] P. Lips. Which circulating level of 25-hydroxyvitamin D is appropriate? , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[8] J. Welsh,et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. , 2003, Molecular endocrinology.
[9] T. Hünig,et al. IL-2 and autoimmune disease. , 2002, Cytokine & growth factor reviews.
[10] L. Freedman,et al. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. , 2002, Journal of immunology.
[11] K. Myhr,et al. Effect of dietary advice and n‐3 supplementation in newly diagnosed MS patients , 2000, Acta neurologica Scandinavica.
[12] P. Eskildsen,et al. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. , 1998, Scandinavian journal of gastroenterology.
[13] H. DeLuca,et al. Vitamin D and autoimmune diabetes , 2003, Journal of cellular biochemistry.
[14] M. Holick,et al. Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. , 1981, Science.
[15] Elina Hyppönen,et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.
[16] P. Goldberg,et al. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. , 1986, Medical hypotheses.
[17] T. Zemunik,et al. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in the Dalmatian population. , 2003, Diabetes research and clinical practice.
[18] M. Cantorna,et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.
[19] C. Mathieu,et al. In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] M. Holick,et al. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.
[21] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[22] J. Franklyn,et al. Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. , 1998, The Journal of rheumatology.
[23] F. Cosman,et al. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation , 2003, Journal of Neuroimmunology.
[24] N. Pejnović,et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. , 1999, Clinical and experimental rheumatology.
[25] J. Todd,et al. The study of CTLA‐4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population , 2002, Journal of cellular and molecular medicine.
[26] O. Majdic,et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. , 2000, Experimental hematology.
[27] W. Sibley,et al. Seasonal variation of multiple sclerosis exacerbations in Arizona , 1983, Neurology.
[28] Huub F. J. Savelkoul,et al. 1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.
[29] D. Goodkin,et al. Seasonal variation of multiple sclerosis exacerbations in North Dakota. , 1989, Archives of neurology.
[30] L. Mosekilde,et al. Inflammatory bowel disease and osteoporosis. , 1997, Scandinavian journal of gastroenterology.
[31] Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. , 2008, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[32] C. Wagner,et al. Assessment of dietary vitamin D requirements during pregnancy and lactation. , 2004, The American journal of clinical nutrition.
[33] M. Holick,et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.
[34] M. Cantorna,et al. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[35] T. Gramlich,et al. Dietary Supplementation with Fish Oil in Ulcerative Colitis , 1992, Annals of Internal Medicine.
[36] M. Rocchi,et al. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. , 2002, Human molecular genetics.
[37] R. Vieth. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[38] T. Meehan,et al. The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. , 2002, Archives of biochemistry and biophysics.
[39] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Rieder,et al. The seasonal incidence of multiple sclerosis in Switzerland. , 1970, European neurology.
[41] R. Kumar,et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.
[42] L. Freedman,et al. 1,25-Dihydroxyvitamin D3 Inhibits IFN-γ and IL-4 Levels During In Vitro Polarization of Primary Murine CD4+ T Cells1 , 2002, The Journal of Immunology.
[43] R. Mutani,et al. Transforming growth factor β1 (TGFβ1) mRNA level correlates with magnetic resonance imaging disease activity in Multiple Sclerosis patients , 1999, Neuroscience Letters.
[44] R. Bretzel,et al. VDR gene polymorphisms are overrepresented in german patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[45] M. Cantorna,et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells , 2003, Journal of cellular biochemistry.
[46] C. Gössl,et al. Seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.
[47] P. Allavena,et al. Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.
[48] R. Mutani,et al. Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. , 1999, Neuroscience letters.
[49] T. Saruta,et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[50] A. Sadovnick,et al. Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.
[51] M. Uskoković,et al. A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .
[52] R. Vieth,et al. Vitamin D and seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.
[53] D. Jewell,et al. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility , 2000, Gut.
[54] R. Vieth,et al. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. , 2001, The American journal of clinical nutrition.
[55] S. Kikuchi,et al. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS , 2002, Journal of Neuroimmunology.
[56] H. Drexhage,et al. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. , 2001, European journal of endocrinology.
[57] Joanne I. Yeh,et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population , 2000, Clinical endocrinology.
[58] K. Miyasaka,et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese , 1999, Journal of the Neurological Sciences.
[59] David F. Richards,et al. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.
[60] G. Triadafilopoulos,et al. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. , 1992, The American journal of gastroenterology.
[61] J. Cerhan,et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.
[62] N. Risch,et al. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients , 2000, Neurology.